PP
CVS icon

PFS Partners’s CVS Health CVS Stock Holding History

PFS Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21K Hold
31
– – ﹤0.01% 502
2026
Q1 		$2.23K Hold
31
– – ﹤0.01% 511
2025
Q4 		$2.46K Sell
31
-808
-96% -$63.7K ﹤0.01% 501
2025
Q3 		$63.3K Buy
839
+39
+5% +$2.67K 0.03% 152
2025
Q2 		$55.2K Sell
800
-272
-25% -$17.8K 0.03% 153
2025
Q1 		$72.7K Buy
1,072
+12
+1% +$718 0.04% 124
2024
Q4 		$47.6K Buy
1,060
+12
+1% +$673 0.03% 151
2024
Q3 		$65.9K Sell
1,048
-88
-8% -$5.13K 0.04% 119
2024
Q2 		$67.1K Buy
1,136
+10
+0.9% +$626 0.04% 107
2024
Q1 		$89.8K Buy
1,126
+9
+0.8% +$687 0.06% 93
2023
Q4 		$88.2K Buy
1,117
+9
+0.8% +$641 0.06% 94
2023
Q3 		$77.4K Buy
1,108
+8
+0.7% +$567 0.07% 80
2023
Q2 		$76K Buy
1,100
+1,000
+1,000% +$71.2K 0.06% 84
2023
Q1 		$7.43K Hold
100
– – 0.01% 244
2022
Q4 		$9.32K Hold
100
– – 0.01% 215
2022
Q3 		$9.54K Hold
100
– – 0.01% 200
2022
Q2 		$9.27K Sell
100
-36
-26% -$3.51K 0.01% 206
2022
Q1 		$13.8K Hold
136
– – 0.01% 189
2021
Q4 		$14K Buy
+136
New +$12.6K 0.01% 182

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

PFS Partners's CVS Position: Q2 2026 in Review

PFS Partners held its CVS Health (CVS) position steady in Q2 2026 at 31 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

PFS Partners first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $89.8K in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • PFS Partners held 31 shares of CVS Health worth $3.21K as of Q2 2026.
  • PFS Partners left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #502 holding.
  • PFS Partners first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • PFS Partners's CVS Health position peaked at $89.8K in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.